Centers for Mendelian Genomics (UM1)

The summary for the Centers for Mendelian Genomics (UM1) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Centers for Mendelian Genomics (UM1): This FOA invites applications for the Centers for Mendelian Genomics Program (CMG Program). With this reissuance, NHGRI intends to achieve the following specific objectives. First, the Program will aim to discover as many genes that bear causal genetic variants ("causal genes") for human Mendelian diseases and non-disease Mendelian traits ("Mendelian conditions") as possible, using genome-wide sequencing and other complementary genomic approaches at the funded centers, and through collaborations with clinical and genetic researchers worldwide. Second, the Program will aim to enhance the chances of success in causal gene discoveries by improving sample solicitation strategies, discovery approaches, study designs, data analysis methods, and costs and efficiency of the discovery pipelines. Third, the Program will aim to enable others to discover more causal genes by disseminating the methods, tools, and other resources that will be developed under this FOA. Finally, the Program will facilitate common interests-based collaborations and avoid unproductive duplication of efforts on causal gene discoveries, through worldwide coordination. At a higher level, NHGRI intends that these activities will lead to insights on what methods, scale, and infrastructure will be necessary to discover all or most of the causal genes for human Mendelian conditions, and bring the field forward toward this goal.

Federal Grant Title:	Centers for Mendelian Genomics (UM1)
Federal Agency Name:	National Institutes of Health
Grant Categories:	Health
Type of Opportunity:	Discretionary
Funding Opportunity Number:	RFA-HG-15-002
Type of Funding:	Cooperative Agreement
CFDA Numbers:	93.172
CFDA Descriptions:	Human Genome Research
Current Application Deadline:	Apr 7, 2015
Original Application Deadline:	Apr 7, 2015
Posted Date:	Dec 12, 2014
Creation Date:	Dec 12, 2014
Archive Date:	May 8, 2015
Total Program Funding:	$40,000,000
Maximum Federal Grant Award:	$5,000,000
Minimum Federal Grant Award:	none
Expected Number of Awards:
Cost Sharing or Matching:	No

Applicants Eligible for this Grant: Native American tribal organizations (other than Federally recognized tribal governments)
Others (see text field entitled "Additional Information on Eligibility" for clarification)
City or township governments
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Private institutions of higher education
For profit organizations other than small businesses
Native American tribal governments (Federally recognized)
Independent school districts
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Public and State controlled institutions of higher education
Small businesses
State governments
Special district governments
County governments
Public housing authorities/Indian housing authorities
Additional Information on Eligibility: Other Eligible Applicants include the following:
Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.
Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
Link to Full Grant Announcement: http://grants.nih.gov/grants/guide/rfa-files/RFA-HG-15-002.html
Grant Announcement Contact: NIH OER Webmaster [email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster

National Institutes of Health 301-496-3405
Similar Government Grants: • Addressing Health Inequities in Clinical Diagnostics (R41/R42 Clinical Trials Not Allowed); • Addressing Health Inequities in Clinical Diagnostics (R43/R44 Clinical Trials Not Allowed); • NHGRI Technology Development Coordinating Center (U24 Clinical Trial Not Allowed); • Solutions to Enable Regional Genomic Medicine eConsult Services (R41/R42 Clinical Trial Op...; • Research on the Impact of and Methods for Implementing Regional Genomic Medicine eConsult ...; • Near-Term Technology Development for Genome Sequencing - SBIR (R43/R44); • Near-Term Technology Development for Genome Sequencing - STTR (R41/R42); • Revolutionary Genome Sequencing Technologies - The $1000 Genome - SBIR (R43/R44)
More Grants from the National Institutes of Health: • The NCI Worta McCaskill-Stevens Career Development Award for Community Oncology and Preven...; • Interventions to Reduce Sleep Health Disparities (R01 - Clinical Trials Optional); • Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Tri...; • Promoting Broad Participation in NIDCD's Extramural Workforce through Research Education E...; • HEAL Initiative-Early-Stage Discovery of New Pain Targets Within the Understudied Druggabl...